|This Slide: #18 of 68|
Slide #18. Omnicell, Inc. — SurgiChem Limited
Omnicell, Inc. (NASDAQ:OMCL)
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced that it has signed an agreement with Bupa Care Homes (CFG) plc to purchase the entire outstanding share capital of SurgiChem Limited, a wholly-owned subsidiary of Bupa, for 12,000,000 subject to certain adjustments, in a cash transaction.
Omnicell is a provider of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Co. provides a range of automation, including robotics designed to digitize and streamline workflows and reduce human error in central pharmacy and clinical areas, and to support medication adherence initiatives in retail pharmacies. Co.'s automation products and services include central pharmacy automation solutions for both dispensing and IV compounding systems, medication and supply dispensing systems at the point of care, as well as medication adherence solutions which are used by retail, community, and outpatient pharmacies.
OMCL SEC Filing Email Alerts Service
Open the OMCL Page at The Online Investor »
Strong Buy (3.50 out of 4)